Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Testicular Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 164Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Costs and Cost Analysis × Clear all
NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

H. Lee Moffitt Cancer Center and Research Institute

Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04531709 2025-07-14

Financial Toxicity and Quality of Life in Patients With TGCT

The University of Texas Health Science Center at San Antonio

Completed
24 enrolled
Genitourinary

Testicular Neoplasms

NCT05100277 2022-01-06

Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective

Hospital Perola Byington

Completed
155 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡